Nalaganje...
New possibilities of pharmacotherapy for systemic lupus erythematosus: Prospects for the use of anifrolumab (monoclonal antibodies to type I interferon receptor)
Systemic lupus erythematosus (SLE) is a systemic autoimmune rheumatic disease of unknown etiology, characterized by overproduction of organ-specific autoantibodies to various components of the cell nucleus and the development of immune-inflammatory damage to internal organs. According to modern conc...
Shranjeno v:
Main Authors: | , , |
---|---|
Format: | Artigo |
Jezik: | Russo |
Izdano: |
IMA-PRESS LLC
2021-10-01
|
Serija: | Научно-практическая ревматология |
Teme: | |
Online dostop: | https://rsp.mediar-press.net/rsp/article/view/3072 |
Oznake: |
Označite
Brez oznak, prvi označite!
|